Kibow Therapeutics
PrivateLast Round
Series A
May 17, 2022
Total Funding Raised
$2.53M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Kibow Therapeutics is a biotechnology company that develops live biotherapeutic products for the treatment of chronic kidney disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, D2C Brands, Drug Discovery
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kibow Therapeutics Comparables
Compare Kibow Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Notitia Biotechnologies | 71% | |
| Sanzyme Private Limited | 70% | |
| Rasa Industries, Ltd. | 61% |
Kibow Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 17, 2022 | ||||
| Grant | Dec 15, 2003 | ||||
| Grant | Jan 1, 2002 |
Kibow Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 82% MoM.
- Jun 23, 2026
Monthly visitors grew 1786% MoM, reaching 1.5K.
Kibow Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Kibow Therapeutics's valuation, stock price, and market status.
Is Kibow Therapeutics a public or private company?
Kibow Therapeutics is a private company.
What is the current stock price of Kibow Therapeutics?
Kibow Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Kibow Therapeutics worth (valuation)?
Valuation information for Kibow Therapeutics is not publicly available.
Can I buy Kibow Therapeutics stock?
Kibow Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Kibow Therapeutics's last funding round?
Kibow Therapeutics's most recent funding round was Series A on May 17, 2022.
Who are the main investors in Kibow Therapeutics?
Key investors in Kibow Therapeutics include National Institute of Diabetes and Digestive and Kidney Diseases.
Will Kibow Therapeutics IPO soon?
No public IPO plans have been announced for Kibow Therapeutics.
How can I track Kibow Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kibow Therapeutics's secondary market activity and sign up for updates.